EURO-CHLORHEXIDINE MOUTHWASH

Negara: Kanada

Bahasa: Inggris

Sumber: Health Canada

Beli Sekarang

Unduh Karakteristik produk (SPC)
14-06-2023

Bahan aktif:

CHLORHEXIDINE GLUCONATE

Tersedia dari:

EURO-PHARM INTERNATIONAL CANADA INC

Kode ATC:

A01AB03

INN (Nama Internasional):

CHLORHEXIDINE

Dosis:

0.12%

Bentuk farmasi:

MOUTHWASH

Komposisi:

CHLORHEXIDINE GLUCONATE 0.12%

Rute administrasi :

BUCCAL

Unit dalam paket:

500ML/4L

Jenis Resep:

Prescription

Area terapi:

MISCELLANEOUS ANTI-INFECTIVES

Ringkasan produk:

Active ingredient group (AIG) number: 0107629007; AHFS:

Status otorisasi:

APPROVED

Tanggal Otorisasi:

2017-04-05

Karakteristik produk

                                1
PRODUCT MONOGRAPH
PR
EURO-CHLORHEXIDINE
Chlorhexidine Gluconate Oral Rinse
0.12% w/v
House Standard
ANTIGINGIVITIS ORAL RINSE
EURO-PHARM INTERNATIONAL CANADA INC.
9400 BOUL. LANGELIER
MONTREAL, QUEBEC
H1P 3H8
CONTROL NUMBER: 275418
DATE OF PREPARATION:
APR 05, 2017
DATE OF
REVISION:
JUN 14, 2023
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
........................................................ 3
SUMMARY PRODUCT INFORMATION
.......................................................................
3
INDICATIONS AND CLINICAL USE
.............................................................................
3
CONTRAINDICATIONS
..................................................................................................
3
WARNINGS AND PRECAUTIONS
.................................................................................
4
ADVERSE REACTIONS
...................................................................................................
5
DRUG INTERACTIONS
...................................................................................................
5
DOSAGE AND ADMINISTRATION
...............................................................................
5
OVERDOSAGE
.................................................................................................................
6
ACTION AND CLINICAL PHARMACOLOGY
............................................................. 7
STORAGE AND STABILITY
...........................................................................................
8
DOSAGE FORMS, COMPOSITION AND PACKAGING
.............................................. 8
PART II: SCIENTIFIC INFORMATION
................................................................................
9
PHARMACEUTICAL INFORMATION
...........................................................................
9
CLINICAL TRIALS
.........................................................................................................
10
TOXICOLOGY
..........................................................
                                
                                Baca dokumen lengkapnya
                                
                            

Dokumen dalam bahasa lain

Karakteristik produk Karakteristik produk Prancis 14-06-2023

Peringatan pencarian terkait dengan produk ini